LONDON, Sept. 09, 2021 (GLOBE NEWSWIRE) — OKYO Pharma Limited (LSE: OKYO), the life sciences and biotechnology company focused on the discovery and development of novel molecules to treat inflammatory dry eye diseases and chronic pain, is pleased to announce…
